Signal active
Organization
Contact Information
Overview
ZetaGen Therapeutics is commercializing a small molecule-based osteoinductive platform technology to develop bone growth products that activate a novel molecular pathway.
ZetaGen Therapeutics's goal is to halt cancer, reduce pain, and rebuild bones. The company's solution has the potential to revolutionize the treatment of bone-related injuries, operations, and diseases, resulting in better outcomes for both patients and doctors.
About
Health Care, Medical Device, Therapeutics
2015
11-50
Headquarters locations
New York, United States, North America
Social
N/A
Profile Resume
ZetaGen Therapeutics headquartered in New York, United States, North America, operates in the Health Care, Medical Device, Therapeutics sector. The company focuses on Health Care and has secured $1.0B in funding across 72 round(s). With a team of 11-50 employees, ZetaGen Therapeutics is actively contributing to advancements in Health Care. Their latest funding round, Series B - ZetaGen Therapeutics, raised $9.8M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
6
2
0
$14.4M
Details
5
ZetaGen Therapeutics has raised a total of $14.4M in funding over 5 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2017 | Seed | 1.7M | ||
2018 | Seed | |||
2022 | Early Stage Venture | |||
2023 | Early Stage Venture | 9.8M |
Investors
ZetaGen Therapeutics is funded by 7 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
New York Ventures | - | FUNDING ROUND - New York Ventures | undefined |
New York Ventures | - | FUNDING ROUND - New York Ventures | 9.8M |
ZetaGen Therapeutics | - | FUNDING ROUND - ZetaGen Therapeutics | 9.8M |
Consolidated Investment Group | - | FUNDING ROUND - Consolidated Investment Group | 9.8M |
Recent Activity
There is no recent news or activity for this profile.